By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



2611 SW 3rd Avenue

Portland  Oregon  97201  U.S.A.
Phone: 888-663-7382 Fax: 503-459-4976



Company News
Asterand Bioscience And MolecularMD Announce A Partnership To Accelerate Targeted Therapeutic Biomarker Validation, Optimization, Development And Commercialization 2/15/2017 8:49:33 AM
Definiens AG And MolecularMD Announce Partnership To Combine IHC Assays With Advanced Digital Pathology And Data Mining 6/2/2016 11:07:43 AM
MolecularMD Receives New York State Approval For Next Generation Sequencing Test To Support Clinical Trial Enrollment 7/17/2015 4:55:19 PM
MolecularMD Cambridge Laboratory Receives CAP Accreditation With Focus On NGS Panels For Clinical Trial Enrollment And NGS Liquid Biopsy Testing 12/18/2014 11:21:03 AM
MolecularMD Develops Notch1 Next Generation Sequencing Test To Support Clinical Development For OncoMed Pharmaceuticals, Inc. (OMED)'s Anti-Notch1 Antibody, OMP-52M51 6/12/2014 10:08:39 AM
MolecularMD Receives CLIA Certification For Its Second Next Generation Sequencing Laboratory 4/7/2014 10:37:31 AM
MolecularMD Launches NanoString Platform For Multiplexed Digital Evaluation Of Gene Expression And Copy Number Variation In Clinical Specimens 3/6/2014 9:19:33 AM
MolecularMD To Develop Highly Sensitive Companion Diagnostic Test To Support CML Treatment Free Remission Clinical Trials 2/19/2014 10:16:10 AM
MolecularMD Announces Presentations at Upcoming American Society of Hematology Annual Meeting 12/5/2013 9:52:01 AM
Personal Genome Diagnostics and MolecularMD Collaborate to Provide Advanced Genomic Testing Services to Cancer Drug Developers 10/25/2013 10:01:42 AM